DPBIO Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 5

DPBIO General Information

Description

Developer of microfluidics technology designed to accelerate discovery in biomedical research. The company's platform delivers ultra-high-throughput single-cell resolution for applications such as antibody discovery, enzyme screening, and related assays, incorporating droplet-based microfluidics, scalable experimental workflows, and precise cellular analysis, enabling pharmaceutical companies, biotechnology researchers, and academic laboratories to conduct detailed investigations, improve screening efficiency, and advance innovation in drug development and life sciences research.

Contact Information

Website
www.dp-bio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6888 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6888 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DPBIO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 15-Jun-2026 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jan-2021 Completed Generating Revenue
3. Seed Round 01-Jan-2020 Completed Generating Revenue
2. Angel (individual) 01-Jan-2020 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
To view DPBIO’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

DPBIO Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hiway Capital Venture Capital Minority
Shanghai Pudong Venture Capital Venture Capital Minority
Shanghai Science and Technology Innovation Center Equity Investment Fund Management Fund of Funds Minority
Shenzhen Nanshan Strategic Emerging Industry Investment Government Minority
Hong Kong University of Science and Technology (Guangzhou) Accelerator/Incubator
To view DPBIO’s complete investors history, request access »

Ready to get started?

Request a free trial

DPBIO FAQs

  • When was DPBIO founded?

    DPBIO was founded in 2018.

  • Where is DPBIO headquartered?

    DPBIO is headquartered in San Diego, CA.

  • What industry is DPBIO in?

    DPBIO’s primary industry is Discovery Tools (Healthcare).

  • Is DPBIO a private or public company?

    DPBIO is a Private company.

  • What is DPBIO’s current revenue?

    The current revenue for DPBIO is .

  • Who are DPBIO’s investors?

    Hiway Capital, Shanghai Pudong Venture Capital, Shanghai Science and Technology Innovation Center Equity Investment Fund Management, Shenzhen Nanshan Strategic Emerging Industry Investment, and Hong Kong University of Science and Technology (Guangzhou) have invested in DPBIO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process